Skip to content

Author

Zhanxiong Xie

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world safety of vericiguat as a fifth-line agent in heart failure: a pharmacovigilance study of quintuple therapy

Background Vericiguat, a novel soluble guanylate cyclase (sGC) stimulator, is indicated for high-risk worsening heart failure (HF). However, its real-world reporting profile when added to contemporary quadruple guideline-directed medical therapy (GDMT)—effectively creating a “quintuple” regimen—remains largely unexplor...

Da-Qiu Chen, Y. Wu, Zi-Xun Wang et al. · 0 citations
Review Open access Sep 2026

Divergent mortality associations of TyG-BMI in middle-aged and older adults: Parallel analyses of Chinese and US populations.

The association between TyG-BMI and all-cause mortality differed between Chinese and US middle-aged and older adults, and TyG-BMI provided little or no incremental prognostic discrimination beyond BMI alone, which supports cautious, population-specific interpretation of TyG-BMI.

Da-Qiu Chen, Zi-Xun Wang, Zhan-Xiong Xie et al. · 0 citations
Review Open access Aug 2026

Gut-derived metabolites and mitochondrial homeostasis in heart failure: mechanistic links and translational perspectives

Current evidence linking gut-derived metabolites to myocardial mitochondrial homeostasis in heart failure is summarized, with emphasis on energy metabolic remodeling, oxidative stress, inflammation, mitochondrial quality control, cell death, and fibrotic remodeling.

Da-Qiu Chen, Ming-Xuan Su, Zhan-Xiong Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.